Therefore, one can reason that sustained exposure of ES-HNSCC cells to erlotinib-induced IL-α may have led to the dependency of HNSCC cells on IL-1 signaling for survival. Here, TNFRSF9 is linked to head and neck squamous cell carcinoma.